New hope drug tested for patients out of treatment options
NCT ID NCT07446816
Summary
This is an early-stage study testing a new drug called Hemay181 in patients with advanced solid tumors that have stopped responding to standard treatments. The main goals are to see if the drug is safe and if it can shrink tumors. The study will enroll about 24 patients who have no other effective therapies available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Xinxiang Medical University First Affiliated Hospital
RECRUITINGXinxiang, Henan, 45310, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.